Replimune Group Inc (NASDAQ:REPL) price on Friday, May 02, rose 3.84% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $10.01.
A look at the stock’s price movement, the close in the last trading session was $9.64, moving within a range at $9.715 and $10.21. The beta value (5-Year monthly) was 1.265. Turning to its 52-week performance, $17.00 and $4.92 were the 52-week high and 52-week low respectively. Overall, REPL moved 16.13% over the past month.
Replimune Group Inc’s market cap currently stands at around $770.92 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Feb-11.
Turning to the stock’s technical picture we see that short term indicators suggest on average that REPL is a 50% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
5 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 5 recommend REPL as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
REPL’s current price about 19.87% and -1.73% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 60.72, while 7-day volatility ratio is 5.03% and 8.16% in the 30-day chart. Further, Replimune Group Inc (REPL) has a beta value of 0.68, and an average true range (ATR) of 0.64. Analysts have given the company’s stock an average 52-week price target of $23, forecast between a low of $19 and high of $27. Looking at the price targets, the low is -89.81% off current price level while to achieve the yearly target high, price needs to move -169.73%. Nonetheless, investors will most likely welcome a -129.77% jump to $23 which is the analysts’ median price.
If we refocus on Replimune Group Inc (NASDAQ:REPL), historical trading data shows that trading volumes averaged 0.87 over the past 10 days and 761.36K over the past 3 months. The company’s latest data on shares outstanding shows there are 77.01 million shares.
The 19.76% of Replimune Group Inc’s shares are in the hands of company insiders while institutional holders own 88.95% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 8.83 million on 2025-04-15, giving us a short ratio of 9.48. The data shows that as of 2025-04-15 short interest in Replimune Group Inc (REPL) stood at 1581.0001000000002 of shares outstanding, with shares short falling to 9.55 million registered in 2025-03-14. Current price change has pushed the stock -17.34% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the REPL stock continues to rise going into the next quarter.
